tetano
Editor, Senior Moderator
Vaccines (Basel). 2020 Feb 3;8(1). pii: E65. doi: 10.3390/vaccines8010065. [h=1]MiRNA Targeted NP Genome of Live Attenuated Influenza Vaccines Provide Cross-Protection against a Lethal Influenza Virus Infection.[/h]
Gao F[SUP]1,[/SUP][SUP]2[/SUP], Yang T[SUP]1[/SUP], Liu X[SUP]1[/SUP], Xiong F[SUP]1[/SUP], Luo J[SUP]1[/SUP], Yi Y[SUP]1[/SUP], Fan J[SUP]1[/SUP], Chen Z[SUP]1[/SUP], Tan WS[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The miRNA-based strategy has been used to develop live attenuated influenza vaccines. In this study, the nucleoprotein (NP) genome segment of the influenza virus was inserted by different perfect miRNA-192-5p target sites, and the virus was rescued by standard reverse genetics method, so as to verify the virulence and protective efficacy of live attenuated vaccine in cells and mice. The results showed there was no significant attenuation in 192t virus with one perfect miRNA-192-5p target site, and 192t-3 virus with three perfect miRNA target sites. However, 192t-6 virus with 6 perfect miRNA target sites and 192t-9 virus with 9 perfect miRNA target sites were both significantly attenuated after infection, and their virulence were similar to that of temperature-sensitive (TS) influenza A virus (IAV) which is a temperature-sensitive live attenuated influenza vaccine. Mice were immunized with different doses of 192t-6, 192t-9, and TS IAV. Four weeks after immunization, the IgG in serum and IgA in lung homogenate were increased in the 192t-6, 192t-9, and TS IAV groups, and the numbers of IFN-γ secreting splenocytes were also increased in a dose-dependent manner. Finally, 192t-6, and 192t-9 can protect the mice against the challenge of homologous PR8 H1N1 virus and heterosubtypic H3N2 influenza virus. MiRNA targeted viruses 192t-6 and 192t-9 were significantly attenuated and showed the same virulence as TS IAV and played a role in the cross-protection.
[h=4]KEYWORDS:[/h] NP; cross-protection; influenza virus; live attenuated influenza vaccine; miRNA-192-5p
PMID: 32028575 DOI: 10.3390/vaccines8010065
Free full text
Gao F[SUP]1,[/SUP][SUP]2[/SUP], Yang T[SUP]1[/SUP], Liu X[SUP]1[/SUP], Xiong F[SUP]1[/SUP], Luo J[SUP]1[/SUP], Yi Y[SUP]1[/SUP], Fan J[SUP]1[/SUP], Chen Z[SUP]1[/SUP], Tan WS[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The miRNA-based strategy has been used to develop live attenuated influenza vaccines. In this study, the nucleoprotein (NP) genome segment of the influenza virus was inserted by different perfect miRNA-192-5p target sites, and the virus was rescued by standard reverse genetics method, so as to verify the virulence and protective efficacy of live attenuated vaccine in cells and mice. The results showed there was no significant attenuation in 192t virus with one perfect miRNA-192-5p target site, and 192t-3 virus with three perfect miRNA target sites. However, 192t-6 virus with 6 perfect miRNA target sites and 192t-9 virus with 9 perfect miRNA target sites were both significantly attenuated after infection, and their virulence were similar to that of temperature-sensitive (TS) influenza A virus (IAV) which is a temperature-sensitive live attenuated influenza vaccine. Mice were immunized with different doses of 192t-6, 192t-9, and TS IAV. Four weeks after immunization, the IgG in serum and IgA in lung homogenate were increased in the 192t-6, 192t-9, and TS IAV groups, and the numbers of IFN-γ secreting splenocytes were also increased in a dose-dependent manner. Finally, 192t-6, and 192t-9 can protect the mice against the challenge of homologous PR8 H1N1 virus and heterosubtypic H3N2 influenza virus. MiRNA targeted viruses 192t-6 and 192t-9 were significantly attenuated and showed the same virulence as TS IAV and played a role in the cross-protection.
[h=4]KEYWORDS:[/h] NP; cross-protection; influenza virus; live attenuated influenza vaccine; miRNA-192-5p
PMID: 32028575 DOI: 10.3390/vaccines8010065
Free full text